The main utero-contracting activity of an aqueous extract of Ardisia crispa (Thunb.) A. DC. is due to two new triterpenic saponins called ardisiacrispin A and B, respectively. The saponins were isolated by extraction with n-butanol, followed by chromatography on silica gel columns. Final purification was obtained by reversed phase HPLC. 13C-NMR identified the aglycone of both saponins as cyclamiretin A. The structure of the ardisiacrispins was deduced by sugar and methylation analysis in combination with 1H- and 13C-NMR spectral data. Ardisiacrispin A is 3β-O-{-β-D-xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→4)-[O-β-D-glucopyranosyl-(1→2)]-α-L-arabinopyranosyl}-16α-hydroxy-13β,28-epoxyolean-30-al. Ardisiacrispin B is: 3β-O-{α-L-rhamnnopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→4)-[O-β-D-glucopyranosyl-(1→2)]-α-L-arabinopyranosyl}-16α-hydroxy-13β,28-epoxyolean-30-al. At a concentration in the bath of 8 µg/ml both saponins gave contractive responses of the isolated rat uterus corresponding to 84% of the contraction caused by a standard dose of acetyl choline (0.2 µg/ml).
Ardisia crispa, ardisiacrispin A, ardisiacrispin B, triterpenic saponin
The publication contains the following compound(s):|
Show legend Show as text |
|
Show legend Show as text |
| New query | Export IDs | Home | Help |
Execution: <1 sec